Katayama, Sadao
Tsujimoto, Masashi
Suzuki, Keisuke
Ueda, Kaname https://orcid.org/0000-0003-1967-9829
Shimoura, Kanako
Suo, Shintaro
Hatakeyama, Naohisa
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 25 August 2025
Accepted: 17 November 2025
First Online: 27 November 2025
Declarations
:
: Sadao Katayama received consultancy fees from Eisai Co. Ltd. Kanako Shimoura and Shintaro Suo are employees of Mebix, Inc, which was outsourced by Eli Lilly and Company to perform this study. Kaname Ueda and Naohisa Hatakeyama are employees of Eli Lilly Japan K.K. and hold shares in Eli Lilly and Company. Masashi Tsujimoto and Keisuke Suzuki have no conflict of interest to declare.
: This study was conducted in accordance with the Declaration of Helsinki, Ethical Guidelines for Medical and Biological Research involving Human Subjects, and Japanese laws and regulations, and was approved by the Takahashi Clinic Ethics Committee (LNW00216). To enroll in this study, all participants were asked for and provided written informed consent. All of the data collected were processed and stored in accordance with the law on the protection of personal information.